Not yet a member?Join now!|Lost password
ZELTIQ Aesthetics Inc.
ZELTIQ Aesthetics Inc.
11/07/2012 | Press release
ZELTIQ to Report Third Quarter 2012 Financial Results on November 7, 2012
distributed by noodls on 11/08/2012 11:22
PLEASANTON, Calif., Oct. 18, 2012 (GLOBE NEWSWIRE) -- ZELTIQ® Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its third quarter 2012 financial results on Wednesday, November 7, 2012 after the market close.
ZELTIQ will hold a conference call on Wednesday, November 7, 2012, 2012 at 5:00 p.m. ET to discuss the results. The dial-in numbers are (877) 280-7291 for domestic callers and (707) 287-9361 for international callers. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.coolsculpting.com.
After the live webcast, the call will remain available on ZELTIQ's website, www.coolsculpting.com, through December 7, 2012. In addition, a telephonic replay of the call will be available until November 14, 2012. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay pin number 48280896.
About ZELTIQ Aesthetics
ZELTIQ Aesthetics is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The Company's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer within a treated fat bulge without requiring the patient to diet or exercise.
CONTACT: Mark Foley
ZELTIQ Aesthetics, Inc.
President and CEO
925-474-2500
Nick Laudico / Amy Glynn
The Ruth Group
646-536-7030 / 7023
nlaudico@theruthgroup.com
aglynn@theruthgroup.com
Source: ZELTIQ Aesthetics, Inc.
News Provided by Acquire Media
